Literature DB >> 23009379

Symptom burden: a forgotten area of measurement in inflammatory bowel disease.

Dawn Farrell1, Eileen Savage.   

Abstract

Inflammatory bowel disease (IBD) collectively known as Crohn's disease and ulcerative colitis are chronic inflammatory diseases of the digestive tract. Periods of active and inactive disease are common along the trajectory of this illness. A range of symptoms such as fatigue, diarrhoea and abdominal pain are experienced and are often very debilitating in nature resulting in significance interference in daily life. Despite this, to date, research in the area of symptoms remains an underexplored topic. This paper aims to discuss current approaches to symptom assessment in IBD and the potential to measure symptom burden in further research, in order to gain a greater understanding into the experiences of individuals with IBD.
© 2012 Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23009379     DOI: 10.1111/j.1440-172X.2012.02063.x

Source DB:  PubMed          Journal:  Int J Nurs Pract        ISSN: 1322-7114            Impact factor:   2.066


  6 in total

1.  Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease.

Authors:  Dawn Farrell; Geraldine McCarthy; Eileen Savage
Journal:  J Crohns Colitis       Date:  2015-11-22       Impact factor: 9.071

2.  Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs.

Authors:  Ainsley M Robinson; Sarah Miller; Natalie Payne; Richard Boyd; Samy Sakkal; Kulmira Nurgali
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

3.  Self-Care Among Patients With Inflammatory Bowel Disease: An Interview Study.

Authors:  Ulrica Lovén Wickman; Pia Yngman-Uhlin; Henrik Hjortswang; Barbara Riegel; Henrik Stjernman; Gunilla Hollman Frisman
Journal:  Gastroenterol Nurs       Date:  2016 Mar-Apr       Impact factor: 0.978

4.  Social stress-enhanced severity of Citrobacter rodentium-induced colitis is CCL2-dependent and attenuated by probiotic Lactobacillus reuteri.

Authors:  A R Mackos; J D Galley; T D Eubank; R S Easterling; N M Parry; J G Fox; M Lyte; M T Bailey
Journal:  Mucosal Immunol       Date:  2015-09-30       Impact factor: 7.313

5.  "I can fight it!": A qualitative study of resilience in people with inflammatory bowel disease.

Authors:  Dan Luo; Zheng Lin; Xing-Chen Shang; Sha Li
Journal:  Int J Nurs Sci       Date:  2018-12-26

6.  The actuality of resilience, social support and quality of life among patients with inflammatory bowel disease in China.

Authors:  Weiwei Dai; Yufeng Zeng; E Liang; Qiuhong Zhou; Lei Zhang; Jie Peng
Journal:  Nurs Open       Date:  2021-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.